Santen Pharmaceutical Co Ltd (OTCPK:SNPHY)
$ 11.77 -0.82 (-6.51%) Market Cap: 3.79 Bil Enterprise Value: 3.25 Bil PE Ratio: 16.99 PB Ratio: 2.09 GF Score: 79/100

Santen Pharmaceutical Co Ltd Product Invention Presentation Transcript

Oct 07, 2021 / NTS GMT
Release Date Price: $13.56 (-0.07%)

Oct 07, 2021 / NTS GMT
Presentation
Oct 07, 2021 / NTS GMT

=====================
Corporate Participants
=====================
* Hiroki Sakai
* Kenji Morishima
Santen Pharmaceutical Co., Ltd. - Corporate Officer & Head of China Product Development Department
* Peter Sallstig
* Reza Haque
* Shigeo Taniuchi
Santen Pharmaceutical Co., Ltd. - President, CEO & Representative Director

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc. Exchange Research - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Naomi Kumagai
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division - Senior Analyst
* Shohei Oda
Morgan Stanley, Research Division - Research Associate

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot